№ files_lp_3_process_9_69764
File format: docx
Character count: 1409
File size: 238 KB
This leaflet provides patients with instructions and guidelines for undergoing spirometry tests to assess lung function.
Note:
Year
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Department/Practice:
________________________________________________
Address/Location:
__________________________________________________
Service Lead:
__________________________________________________
Standard Operating Protocol:
Performance of Spirometry
Target Audience:
All registered and unregistered healthcare professionals certified in spirometry
Author(s):
Joanna Purvis on behalf of the ARTP Spirometry Committee
Release Date:
13 February 2023
Revision Date:
11 May 2203
Scope:
Standardised procedure for performing dynamic and static spirometry in adults
Equipment:
Spirometer, calibration syringe, stadiometer, scales, barometer, thermometer, disposable mouthpiece, bacterial/viral filter, nose clip, PPE
Infection Control:
Guidelines for cleaning, decontamination, and patient scheduling
Test Procedures:
Relaxed Vital Capacity (SVC), Forced Vital Capacity (FVC), Bronchodilator response
References:
ARTP statement on pulmonary function testing 2020, ATS/ERS 2019 recommendations
Type of Document:
Standard Operating Procedure
Region/Setting:
Healthcare facilities performing spirometry
Year:
2021
Region / city:
Global
Topic:
Spirometry, Restriction, Respiratory Physiology
Document Type:
Learning Record
Institution:
N/A
Author:
N/A
Target Audience:
Healthcare professionals, medical trainees
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / city:
Not specified
Topic:
Spirometry, Lung Function, Medical Education
Document Type:
Educational Resource
Organization:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals, students in medical courses
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Region / city:
UK
Topic:
Spirometry assessment, Certification
Document Type:
Training material
Organization:
ARTP
Author:
ARTP
Target Audience:
Healthcare professionals involved in spirometry testing
Duration:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / City:
UK
Topic:
Spirometry care, medical training
Document type:
Educational resource
Organization / Institution:
ARTP (Association for Respiratory Technology and Physiology)
Author:
ARTP
Target audience:
Healthcare professionals
Period of validity:
Ongoing
Approval date:
2020
Date of revisions:
N/A
Year:
2022
Region / City:
Hertfordshire and West Essex
Theme:
Respiratory Care
Document Type:
Guidelines and Recommendations
Organization:
Hertfordshire and West Essex CCGs
Author:
Dr Corina Ciobanu
Target Audience:
Primary Care Staff
Period of Action:
From May 2021
Approval Date:
February 2022
Review Date:
June 2022
Date of Changes:
February 2022
Changes Summary:
Removal of high-risk pathway, addition of one-way valve
Review Body:
Clinical Leads for Respiratory Services
Year:
2024
Region / City:
Liverpool
Topic:
Sickle Cell Disease, Respiratory Care
Document Type:
Information Leaflet
Author:
Not specified
Target Audience:
Parents and Carers of Children with Sickle Cell Disease
Effective Period:
Indefinite, subject to review
Approval Date:
June 2028
Modification Date:
Not specified
Year:
2024
Region / city:
Barnet
Topic:
EBSA (Emotional Based School Avoidance)
Document type:
Guidance
Institution:
Partnership for Jewish Schools (PaJeS)
Author:
Sinéad O’Callaghan, Kim Miller, Lisa Coffman, Julia Alberga, Jessica Overlander-Kaye, Abigail Freedman, Bracha Hackner, Caron Aspis, Daniel Weisberg, Hannah Martin, Julia Silver, Keren Greene, Naomi Simon, Samantha Cohen, Sara Levan, Sarah Bronzite, Sasha Sharpe, Sophie Driver, Shiri Lader, Suzanne Jaeger, William Hemens
Target audience:
Families and professionals supporting children experiencing EBSA in Jewish schools
Action period:
2024 onwards
Approval date:
2024
Modification date:
Not specified
Note:
Year
Topic:
Data protection, research ethics, participant consent
Document Type:
Template
Target audience:
Researchers conducting non-health-related studies involving personal data
Organisation:
Odiham and Old Basing Health Centres
Type of document:
Patient leaflet
Region:
Hampshire, England
Healthcare system:
NHS
Facilities:
Odiham Health Centre; Old Basing Health Centre
Services covered:
General practice; primary care; community health services
Opening hours:
Monday–Friday
Appointment system:
Telephone triage; face-to-face appointments; online booking
Out-of-hours care:
NHS 111
Emergency contact:
999
Training status:
GP training practice
Patient engagement:
Patient Participation Group
Document audience:
Registered patients and prospective patients
Document purpose:
Patient information and service overview
Contact details included:
Telephone; email; website
Accessibility information:
Parking; disabled access; wheelchair availability
Note:
Year
Region / City:
Barrow in Furness, Cumbria
Subject:
Healthcare Services
Document Type:
Information Leaflet
Organization:
Duke Street Surgery
Target Audience:
Patients of Duke Street Surgery
Context:
A leaflet detailing the healthcare services offered by Duke Street Surgery, including appointments, prescriptions, and various medical services.
Year:
2023
Region / City:
Tallaght, Dublin
Topic:
Research Ethics, Data Protection
Document Type:
Template
Organization:
St James’s Hospital / Tallaght University Hospital
Author:
Joint Research Ethics Committee
Target Audience:
Researchers, Adult Participants, Patients, Parents, Carers
Period of Validity:
N/A
Approval Date:
N/A
Date of Last Update:
N/A
Document No:
FDA/DNC/TEM-02
Date of First Adoption:
1st February 2013
Date of Issue:
8th January 2024
Version No:
03
Issuing Authority:
Food and Drugs Authority, Ghana
Acknowledgement:
World Health Organization (WHO)
Type of Document:
Patient Information Leaflet (PIL)
Target Audience:
Patients and healthcare providers
Content:
Instructions, warnings, side effects, storage, and pharmaceutical information of the medicine
Year:
2019
Regulation:
EU 2019/6
Document type:
Guidance template
Author:
European Union
Target audience:
Applicants of veterinary medicinal products
Approval date:
Not specified
Modification date:
Not specified
Description:
Template for packaging label and leaflet for veterinary medicinal products intended to be included on the immediate packaging, as outlined by EU regulation.
Note:
Year
Topic:
Data Protection, Research Ethics
Document Type:
Guidance
Institution:
Trinity College Dublin
Author:
Trinity College Dublin Data Protection Office
Target Audience:
Researchers
Year:
2023
Region / City:
Ireland
Subject:
Health research, Data protection
Document type:
Guidance document
Institution:
Trinity College Dublin
Author:
Data Protection Office
Target audience:
Researchers conducting health research
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2023
Region / city:
Global
Topic:
Pharmaceutical Information
Document Type:
Patient Information Leaflet (PIL)
Organization / Institution:
World Health Organization (WHO)
Author:
WHO Prequalification Team
Target Audience:
Patients, healthcare providers
Validity Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2026
Region / City:
Russian Federation
Type:
Patient information leaflet
Product:
Grippol® Quadrivalent
Therapeutic group:
Vaccine against influenza (inactivated) with adjuvant
Dosage form:
Solution for intramuscular and subcutaneous injection
Active ingredients:
Influenza virus antigens A(H1N1), A(H3N2), B Yamagata, B Victoria, Azoximer bromide
Indications:
Influenza prophylaxis for children over 6 years, adolescents, adults under 60 years, high-risk and occupational groups
Contraindications:
Allergy to chicken proteins or vaccine components, age under 6, pregnancy (for preservative-containing vaccine), acute illness
Administration:
Intramuscular or deep subcutaneous injection, 0.5 ml per dose, annual vaccination
Storage conditions:
2–8 °C, protect from contamination, follow aseptic rules
Regulatory status:
Marketing authorization in Russia